HAE - צמיחת מכירות משנה לשנה ב-12 החודשים האחרונים Haemonetics Company

Haemonetics Corporation (HAE) is recognized as the gold standard for safety in hematology and blood filtration. This trailing 12-month sales volume growth chart versus the previous year in the GURU.Markets system confirms this status, where 4.10 reflects the metric's baseline. The company creates indispensable infrastructure for transfusion medicine, although its success relies on US demand and the stability of consumable supplies.
פילוחי נתונים אנליטיים מרוכזים עבור Haemonetics (HAE)

Portfolio managers value the scalability of Haemonetics Corporation (HAE), which is driven by consistent sales of high-margin consumables for plasma centers. This indicator measures the percentage change in revenue over a rolling twelve-month period, providing real-time confirmation of fundamental growth through new data. By analyzing the TTM revenue growth rate compared to the previous year, investors can assess the quality of operational performance without temporal gaps. The stable trend here confirms the resilience of the "razor-and-blade" business model.